PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-07-01

Date Title Company
01-Jul-2019 CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019 CSL Behring
01-Jul-2019 CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019 CSL Behring
01-Jul-2019 DotLab Secures $10 Million Series A Funding to Transform the Standard of Care for Endometriosis with the World's First Accurate Non-Invasive Test for the Disease DotLab
01-Jul-2019 Biofrontera AG: In a joint statement, Executive Board and Management Board of Biofrontera AG recommend not to accept the partial acquisition offer of Deutsche Balaton Biotech AG and DELPHI Unternehmensberatung Aktiengesellschaft Biofrontera AG
01-Jul-2019 First Berlin Equity Research Publishes Updated Independent Analysis of Cyxone Cyxone
01-Jul-2019 Dermapharm Holding SE with increased free float Dermapharm Holding SE
01-Jul-2019 Influenza Vaccine Market to Cross USD 6.17 Bn by 2024 | Burgeon CAGR 10.2% Wired Hearld
01-Jul-2019 Left Ventricular Assist Device Treatment Market to Hit USD 2,043 Mn by 2024 with Accelerate CAGR 10.5% Wired Hearld
01-Jul-2019 Immune-Mediated Inflammatory Diseases Treatment Market to surpass USD 153.5 Billion by 2024 | CAGR 6.3% Wired Hearld
01-Jul-2019 Sleeping Aids Market Could Exceed USD 10.9 Billion by 2024 with Vigorous CAGR 6.8% Wired Hearld
01-Jul-2019 Formycon AG: Formycon reports on Annual General Meeting 2019 Formycon AG
01-Jul-2019 CENTOGENE Reveals Growth of Rare Hereditary Disease Knowledge Base CENTOGENE AG
01-Jul-2019 Intec Pharma Announces Publication of Article Reviewing Accordion Pill's Unique Gastric Retention Platform in Therapeutic Delivery Intec Pharma Ltd.
01-Jul-2019 Athira Pharma's Leen Kawas Selected as Young Leader by French-American Foundation Athira Pharma, Inc.
01-Jul-2019 New Trial Shows Cefaly is a Safe and Effective Preventive Treatment for Chronic Migraine CEFALY Technology
01-Jul-2019 Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer Squarex
01-Jul-2019 ActoBio Therapeutics(TM) Progresses AG019 to Next Stage of a Phase Ib/IIa Clinical Study for the Treatment of Type 1 Diabetes ActoBio Therapeutics, Inc.
01-Jul-2019 Biohaven Enrolls First Patient in Phase 2 Clinical Trial of Rimegepant, Oral CGRP Receptor Antagonist, for Treatment Refractory Trigeminal Neuralgia Biohaven Pharmaceutical Holding Company Ltd.
01-Jul-2019 Global Hormon replacement therapy Market Overview by Top Companies & Segmentation Wired Release
01-Jul-2019 Hospital Acquired Infection Diagnostics Market 2019 – Company Overview & Investment Analysis Wired Release